Surfactant via airway device for breathing trouble in newborns
Part of Lungs & breathing clinical trials.
This trial tests if giving surfactant (a natural substance that helps lungs stay open) through a special airway device can help late preterm and early term infants with breathing problems. The goal is to see if this approach works better than current methods without needing a breathing tube.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby must be between 33 and 38 weeks plus 6 days at birth
- Baby must be no more than 6 hours old
- Baby must have moderate to severe breathing trouble (based on a breathing score)
- Baby must need breathing support without a tube
- Parent or guardian must give written permission
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of giving surfactant (a natural substance that helps lungs stay open) to premature babies who need extra breathing support. It aims to find which method works better and is safer for infants born at 29 to 36 weeks.
This study looks at different ways doctors give a life-saving medication called surfactant to premature babies who are struggling to breathe. Researchers want to understand which delivery methods work best and help improve care.
This trial compares two types of surfactant (Calfactant and Poractant Alfa) given through a less invasive method to very premature babies with breathing problems. It aims to see if one works better at helping them breathe without needing a breathing tube.
This study compares two methods—video laryngoscopy and direct laryngoscopy—to give surfactant (a medicine that helps babies' lungs work better) to very premature infants. It aims to find which method is safer and easier for babies born at 28 weeks or earlier who need surfactant within the first 36 hours after birth.
This Phase 3 trial tests whether InfasurfAero™ (a type of surfactant given as aerosol) works better than a sham treatment in preterm babies with respiratory distress syndrome (RDS). It aims to improve breathing in the first hours of life for babies who need CPAP.
This trial tests whether giving surfactant (a substance that helps lungs stay open) to premature babies with Respiratory Distress Syndrome (RDS) through a mask on the throat (supraglottic airway) is safe and effective. It may be an option for babies who need extra oxygen but are not on a breathing tube.
Hear when a new Respiratory Distress Syndrome (Neonatal) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.